InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,432.36
(
0.14%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: knuts4oe post# 28039

Monday, 03/13/2017 1:38:01 PM

Monday, March 13, 2017 1:38:01 PM

Post# of 30990
The "perfect storm" for anatabine went down the drain with Trump's choice of Scott Gottlieb to head the FDA, a win for BIG PHARMA, as he was their choice, and is a loss for RCPIQ, since he will likely continue the current drug approval process, prove safety and efficacy first, which is incredibly expensive and lengthy.

Jim O'Neill's "just prove safety, then let the marketplace and doctors determine efficacy" was ideal for anatabine.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up